39°58′29″N 116°20′24″E / 39.9747°N 116.3401°E
&sq=Qlik&lang=&file=File:China_National_Pharmaceutical_Group_Corporation.png) | |||||||
&sq=Qlik&lang=&file=File:Sinopharm_Building_(20230206145912).jpg) Headquarters | |||||||
| Sinopharm | |||||||
| Company type | State-owned enterprise | ||||||
| Industry | |||||||
| Founded | November 26, 1998 | ||||||
| Headquarters | 20 Zhichun Road, Haidian District, Beijing , China | ||||||
Area served | China, exported worldwide | ||||||
Key people | Liu Jingzhen (chairman & Chinese Communist Party Committee Secretary)[1][2] | ||||||
| Products | |||||||
| Revenue |  US$ 96.1 billion (2023)[3] | ||||||
| US$ 1.1 billion (2023)[3] | |||||||
| Total assets | US$ 82.8 billion (2023)[3] | ||||||
| Owner | Chinese central government (100%) | ||||||
Number of employees | 202,426 (2023)[3] | ||||||
| Subsidiaries |
| ||||||
| Chinese name | |||||||
| Simplified Chinese | 中国医药集团总公司 | ||||||
| Traditional Chinese | 中國醫藥集團總公司 | ||||||
| |||||||
| short Chinese name | |||||||
| Simplified Chinese | 国药集团 | ||||||
| Traditional Chinese | 國藥集團 | ||||||
| |||||||
| Footnotes / references in a consolidated basis; equity and profit excluded minority interests; in Chinese Accounting Standards[4] | |||||||
China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (SEHK: 1099, via a 51–49 joint venture, Sinopharm Industrial Investment, with Fosun Pharmaceutical), China Traditional Chinese Medicine (SEHK: 570, mostly via Sinopharm Group Hongkong Co., Ltd.),[5] Shanghai Shyndec Pharmaceutical (SSE: 600420, via a wholly owned research institute based in Shanghai), and Beijing Tiantan Biological Products (SSE: 600161, via China National Biotec Group).
China National Pharmaceutical Group was supervised by the State-owned Assets Supervision and Administration Commission of the State Council.[6]
Sinopharm was ranked 109th in the 2021 Fortune Global 500 list.[7]
- ^ "中国医药集团有限公司主要领导调整" (in Chinese). Sinopharm. Archived from the original on 2022-09-08. Retrieved 2021-08-24.
- ^ "Liu Jingzhen". Bloomberg.
- ^ a b c d "Sinopharm". Fortune Global 500. Fortune. Retrieved 2024-08-24.
- ^ "中国医药集团总公司2016年度第一期超短期融资券发行披露材料" [Pospectus of 2016 (batch 1) Ultra-short-term financing of Sinopharm]. Sinopharm (in Chinese). Shanghai Clearing House. 19 January 2016. Retrieved 22 November 2016.
- ^ "2015 Annual Report" (PDF). China Traditional Chinese Medicine. Hong Kong Stock Exchange. 28 April 2016. Retrieved 22 November 2016.
- ^ "央企名录 (List of Central SOEs)". Official website of SASAC (in Chinese). Retrieved 3 March 2016.
- ^ "Global 500".